Skip to content
OpenCapital
Get started

Pfizer PFE Biopharma — Investment Income, Dividend

Similar metrics at other companies

Kiniksa Pharmaceuticals International, plc logo
KNSAPharmaceutical — Investment Income Interest
$3.41M+49.1%
Vertex Pharmaceuticals logo
VRTXPharmaceuticals — Interest income, net
$114.8M-2.6%
Ligand Pharmaceuticals logo
LGNDDevelopment and Licensing of Biopharmaceutical Assets — Interest Income
$6.66M+276%
Vertex Pharmaceuticals logo
VRTXPharmaceuticals — income (loss)
$1.03B+59.6%
Labcorp Holdings logo
LHBiopharma Laboratory Services — Operating Income
$120.7M+12.9%
Baxter International logo
BAXPharmaceuticals — Segment operating income
$46M-27.0%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.68B+11.1%
Enterprise value$206.35B+9.2%
P/E11.9×—
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%—
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%—
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeDividend.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's biopharma — investment income, dividend.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's biopharma — investment income, dividend?
Pfizer (PFE) reported biopharma — investment income, dividend of $82M in Q1 2026.
How has Pfizer's biopharma — investment income, dividend changed year-over-year?
Pfizer's biopharma — investment income, dividend increased by 110.3% year-over-year, from $39M to $82M.
What is the long-term trend for Pfizer's biopharma — investment income, dividend?
Over 4 years (2021 to 2025), Pfizer's biopharma — investment income, dividend has grown at a 12.4% compound annual growth rate (CAGR), from $166M to $265M.
What does biopharma — investment income, dividend mean?
Income derived from financial investments, such as dividends or interest, held by the biopharmaceutical segment. This represents non-operating income that contributes to the segment's overall financial health.